Diagnostic performance of non-invasive markers for distinguishing MASLD/MASH: insights from meta-analysis and real-world data
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性，不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
A Patil, SB Mungase, N Mounika, R Adela
Clinica Chimica Acta, 2025
Elsevier
Background The growing prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) underscores the need for early, cost-effective diagnostics to prevent its progression to cirrhosis or liver cancer. This study evaluates the accuracy of non-invasive markers in predicting metabolic-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) through a meta-analysis and cross-sectional validation. Methods A comprehensive literature search (2010–2024) via PubMed and …
